Linfocitos e linfoquinas
Keywords:
Lymphokines, interleukines, cytokines, immune response, lymphocytesAbstract
The lymphocytes and the lymphokines.
The lymphocytes are the major groups of cells that participate in the immune response.
Lymphocytes have T-cell antigen receptors (TCRJ on their membranes.
The antigens are processed by the macropha ges or macrophage-like cells and are presented to T-cells, in the context of major histocompati bility comp"lex (MHCJ mo"lecul,es.
The superantigens that include various bacte rlal products, do not require processing by anti gen-presenting cells, interact directly with inva rlant regions of the MHC mo"lecu"les and stimula te T-cells nonspeciflcally.
The hybridoma technology and monoclonal antibodies has enormously increased the scope of research in Immunology.
Subsets of lymphocytes and other "leukocytes can be differentiated by the antigens oftheir surface. The discrete antigens identified by two or more monoclonal antibodies are designated clusters of di.fferentiation (CD).
Flow cytometry is a great advance in diagnostic immunology and allows the enumeration of the different types of lymphocytes.
The function of the immune system is modulated by numerous signalling compounds produced by lymphoid and other cells (lymphokines, interleukines, stimulating growth factors, etc.) designated generally by cytokines.
The cytokines are implicated in the pathogenesis of certain diseases and are useful in the treatment of the cancer and immunodeflciency diseases.
Downloads
References
Baron S e col. The interferons. Mechanisms of action and clinical applications.J.A.M.A. 1991; 266: 1375-1383.
Becker W M. Monoclonal antibodies. Arb.Paul-Ehrlich-Institut 1988; 82: 107-112.
Claman H N. Toe biology of the immune response.J.A.M.A. 1992;
Degos L. De la greffe à l'histocompatibilité. Presse Méd. 1993; 22: 1511-1514.
Fitch FW. T-cell clones and T-cell receptors. Microbiol.Rev. 1986; 50: 50-69.
Georgiev V, Albright J F. Cytokines and their role as growth factors and in regulation of immune responses. Ann.New York Acad.Sci. 1993; 685: 584-602.
Hamblin T J. Interleukin 2. B.M.J. 1990; 300: 275-276.
Hawkins R E e col. Monoclonal antibodies in Medicine. Adapting antibodies for clinical use. B.M.J. 1992; 305: 1348-1352.
Lanier L L, Jackson A L. Monoclonal antibodies: Differentiation antigens expressed on leukocytes, ln:, Rose,N.R. e col. (eds)
- Manual of Clinicai Laboratory Immunology, 4ed., Am.Soc.Microbiol. Washington 1992, pg. 157-163.
Llewelyn M B e col. Monoclonal antibodies in Medicine. Discovery of antibodies. B.M.J. 1992; 305: 1269-1272.
Mackaness G B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J.Exp.Med.1969; 129: 973-992.
Marx, J.L. - How killer cells kill their targets. Science 1986; 231: 1367-1369.
Misfeldt M L. Microbial "Superantigens". Inf.Immunity 1990; 58:2409-2413.
Plaut M. Cytokines and modulation of diseases of immediate hyper sensitivity. Ann.New York Acad. Sci. 1993; 685: 512-520.
Rossio J L e col. Cytokine testing in clinical trial monitoring, ln: Rose,N.R. e col. (eds) Manual of Clinicai Laboratory lmmunology, 4ª ed., Am.Soc.Microbiol. Washington 1992, pg. 942-947.
Schlievert P M. Role of superantigens in human disease. J.Inf.Dis.1993; 167: 997-1002.
Sculier J P e col. Immunothérapie adoptive par interleukine-2. Presse Med. 1989; 18: 1155-1158.
Sous-Comité de nomenclature OMS-VISI pour les interleukines. Nomenclature des protéines régulatrices sécrétoires du systeme immunitaire (interleukines). Bull. OMS 1991;69: 485--486.
Todd J. A most intimate foe. How the immune system can betray the body it defends. The Sciences, March/April 1990: 20-27.
Tursz T. L'interleukine 2. Place actuelle et avenir en cancérologie. Presse Méd. 1991; 20: 241-243.
Zumla A. Superantigens, T cells and Microbes. Clin.Inf.Dis. 1992; 15: 313-320.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 1994 Internal Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna